Clinical Trial Update: Baclofen for Treating Anxiety and Alcoholism [Phase 2]

View source ↗

Summary

Phase 2 trial update on baclofen for treating anxiety and alcoholism (NIAAA), completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Alcoholism
• Anxiety Disorder

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcoholism, Alcohol Dependence | Phase 2 | Status: COMPLETED | Results posted: 2017-08-16